MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 Reactivation

被引：9

作者：

Peuget, Sylvain ^{[1
]}

Selivanova, Galina ^{[1
,2
]}

机构：

[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden

[2] Karolinska Inst, Biomedicum C8,Solnavagen 9, S-17165 Stockholm, Sweden

来源：

CANCER DISCOVERY | 2023年 / 13卷 / 05期

关键词：

D O I：

10.1158/2159-8290.CD-23-0229

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In this issue of Cancer Discovery , Adams and colleagues present the discovery of a potent PROTAC, MDM2 degrader, which activates wild-type p53 leading to cancer cell death. Importantly, in a number of in vitro and in vivo experiments, the authors show that the depletion of MDM2 by PROTAC kills p53-mutant or p53-null cancer cells.

引用

页码：1043 / 1045

页数：3

共 50 条

[31] Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53
Xirodimas, DP
Stephen, CW
Lane, DP
EXPERIMENTAL CELL RESEARCH, 2001, 270 (01) : 66 - 77
[32] p53和mdm2基因
沈行良
翁启芳
中国热带医学, 2007, (01) : 103 - 105
[33] mdm2/p53与肿瘤
金永丽
王靖华
陈龙邦
临床肿瘤学杂志, 2007, (06) : 469 - 471
[34] Regulation of p53 stability by Mdm2
Michael H. G. Kubbutat
Stephen N. Jones
Karen H. Vousden
Nature, 1997, 387 : 299 - 303
[35] Mdm2: p53's lifesaver?
Shmueli, Ayelet
Oren, Moshe
MOLECULAR CELL, 2007, 25 (06) : 794 - 796
[36] Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Haohao Zhu
Hui Gao
Yingying Ji
Qin Zhou
Zhiqiang Du
Lin Tian
Ying Jiang
Kun Yao
Zhenhe Zhou
Journal of Hematology & Oncology, 15
[37] Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor
Costa, Barbara
Bendinelli, Sara
Gabelloni, Pamela
Da Pozzo, Eleonora
Daniele, Simona
Scatena, Fabrizio
Vanacore, Renato
Campiglia, Pietro
Bertamino, Alessia
Gomez-Monterrey, Isabel
Sorriento, Daniela
Del Giudice, Carmine
Iaccarino, Guido
Novellino, Ettore
Martini, Claudia
PLOS ONE, 2013, 8 (08):
[38] Combination therapy with p53–MDM2 binding inhibitors for malignancies
Zegao Jin
Jianfeng Shen
Jingyao He
Chunqi Hu
Medicinal Chemistry Research, 2015, 24 : 1369 - 1379
[39] Reactivation of p53 signaling in hepatoblastoma with a stapled peptide dual inhibitor of MDM2 and MDM4
Woodfield, Sarah E.
Patel, Roma H.
Ibarra, Aryana M.
Chen, Zhenghu
Vasudevan, Sanjeev A.
CANCER RESEARCH, 2018, 78 (19)
[40] Targeting the MDM2/MDM4 Interaction Interface as a Promising Approach for p53 Reactivation Therapy
Pellegrino, Marsha
Mancini, Francesca
Luca, Rossella
Coletti, Alice
Giacche, Nicola
Manni, Isabella
Arisi, Ivan
Florenzano, Fulvio
Teveroni, Emanuela
Buttarelli, Marianna
Fici, Laura
Brandi, Rossella
Bruno, Tiziana
Fanciulli, Maurizio
D'Onofrio, Mara
Piaggio, Giulia
Pellicciari, Roberto
Pontecorvi, Alfredo
Marine, Jean Christophe
Macchiarulo, Antonio
Moretti, Fabiola
CANCER RESEARCH, 2015, 75 (21) : 4560 - 4572

← 1 2 3 4 5 →